Hi Tony, One question to ask is what do we currently know about biotech companies with synergistic technology.
Phylogica has entered into a number of technology collaborations; Isogenica (fast track screening of drug discovery targets) and XL-protein GmbH (half life extension).
The collaboration with Isogenica was announced 23 February 2011. Note the following statement; "The two companies are exploring a broader alliance to exploit the unique commercial potential of their combined technologies," said Watt.
The announcement discusses the opportunities created by the synergistic technologies including "significant new revenue opportunities".
I always wondered about the deal with Le metier de Beaute. How was it progressed? The announcement yesterday provides some answers. It also opens a door in understanding further opportunities in animal health, agriculture and industrial.
Your research on synthetic phylomers and Biacore is fascinating. I will give more thought over the next couple of days.
Regards,
Wayne.
PYC Price at posting:
1.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)